Sunday, August 13, 2017 4:49:45 PM
10/19/2005 5:12:25 PM
VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- Robert Rieveley, the President of Biotech Holdings has announced that Biotech's Sucanon diabetes drug has received an endorsement from the diabetes support association of the Mexican state with the largest number of diabetics.
"The President of Club Dulce Vida, a diabetic support association in the Mexican state with the greatest number of diabetics, has informed Biotech's Mexico City office that his association is giving its support to the launch of Sucanon in Mexico and has invited Biotech to present at the association's next symposium meeting," Mr. Rieveley said.
"The President of the diabetic association also says, in a letter to Biotech's Mexico City manager, that he has been using Sucanon for one and a half months and has observed that his diabetic symptoms - including blood sugar level, fatigue, thirst and others - have been noticeably reduced and stabilized," Mr. Rieveley said.
"This is the kind of improvement that our data suggest Type II diabetics are likely to show from twice-a-day use of Sucanon," Mr. Rieveley added.
Sucanon, an insulin sensitizer, has shown been shown to be effective and safe for treating symptoms of Type II Diabetes. The Mexico market, with 10 million confirmed diabetics and 10 million pre-diabetics is one of the largest diabetes markets in the world.
Jacob J. Rosenblum on what every lawyer knows.
“If the facts are against you, hammer the law. If the law is against you, hammer the facts. If the fact and the law are against you, hammer opposing counsel."
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM